NURO Neurometrix, Inc. - 8-K

Item 5.02.
  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of
Certain Officers.

On December
27, 2024, Bradley Fluegel notified the Board of Directors (the “Board”) of NeuroMetrix, Inc. (the “Company”) of
his decision to resign from the Board and as a member of the Board’s Audit Committee, effective as of December 31, 2024. Mr. Fluegel’s
decision to resign was not due to any disagreement with the Company on any matter relating to the Company’s operations, policies
or practices.

Effective
as of Mr. Fluegel’s resignation, the Board appointed Joshua Horowitz to the Audit Committee. The Board
determined that Mr. Horowitz qualifies for Audit Committee membership under Nasdaq listing standards and the independence standard for
audit committee members set out in Rule 10A-3 of the Securities and Exchange Act of 1934, as amended.